頁籤選單縮合
題名 | 中央健保局新藥核價作業之評論=The Verification of Prices of New Drugs by Bureau of National Health Insurance |
---|---|
作者 | 陳昭姿; 謝蕙宜; 林敏雄; 黃宇君; 賴美淑; | 書刊名 | 中華民國家庭醫學雜誌 |
卷期 | 8:4 1998.12[民87.12] |
頁次 | 頁210-218 |
分類號 | 419.45 |
關鍵詞 | 中央健保局; 新藥; 核價; New drug; Reimbursment price; |
語文 | 中文(Chinese) |
中文摘要 | 中央健保局在1996年1月至1997年12月間,一共進行了七次新藥與六次申覆案的核價作業,總計124次個新藥品項得到給付價。將新藥價格與廠商申報價、國際中位價、國外最高價、國外最低價比較,其比值分別為0.74、0.90、0.63、1.36。至於核價依據,有58項(46.8%)採藥價比例法,24項(19.4%)採類似品等效量計算法,18項(14.5%)採國際藥價法,12項(9.7%)採類似品加算法,其餘方法為12項(9.6%)。研究顯示,與國際價格比較,新藥價格尚屬合理。作業過程需要改進之處,則包括縮短申請日期與審核時間落差,匯率計算的標準訂定,國際藥價查證的公信力,與類似品的確立及佐證文獻的加強等。 |
英文摘要 | The Bureau of National Health Insuranceconducted the assessment and verification of the prices of new drugs for seven times and reviewed resubmitted cases six times during a period from Jan. 1996 to Dec. 1997. The prices of a total of 99 new drugs were assessed. On comparing the verified prices with the prices requested by the drug supplier, the median prices in 10 advanced countries, the highest and the lowestprices among other countries, the ratios were 0.74, 0.90, 0.63, 1.36 respectively. As for the basis of assessment and verification of the prices, 58 items (46.8%) adopted the ratio method of drug price comparing witha reference drug; 24 items (19.4%) adopted the method of comparing equal efficacy of a reference drug; 18 items (14.5%) adopted the mean prices of 10 advance countries; 12 items (9.7%) adopted the method of reference drug price plus additional allowances and the other 12 items were assessed by using other methods. It is noted that the verification of the prices of new drugs comparing with the international prices is reasonable. Some points suggested to improve in the system of assessment and verification of the prices of new drugs include: shortening the time of submitting application and assessment, setting a reasonable and timely money exchange rate computation mechanism, the reliability of international price information, reference drugs decided and supporting documentation enhanced. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。